Malignant Lymphomas in Sarajevo Region According to WHO Classification of Lymphoid Neoplasms

Authors

  • Ivan Selak Medical Faculty, Institute of Pathology, University of Sarajevo, Bosnia and Herzegovina
  • Nurija Bilalović Medical Faculty, Institute of Pathology, University of Sarajevo, Bosnia and Herzegovina
  • Semir Vranić Medical Faculty, University of Sarajevo, Bosnia and Herzegovina
  • Edin Šabanović Federal Institute of Statistics, Sarajevo, Bosnia and Herzegovina

DOI:

https://doi.org/10.5644/Radovi.358

Keywords:

malignant lymhoma, Hodgkin’s disease (HD), Non-Hodgkin lym-phoma (NHL), W.H.O. Classification, Sarajevo Region

Abstract

Our comparative study concerning malignant lymphoma in Sarajevo Region according to W.H.O. Classification from 1997 in periods 1989-1991 (before the aggression) and 1997-1999 (after the aggression). We expected increased incidence as well as better patient’s survival after the war duo to better diagnostic and therapeutic procedures.

The study included reclassification of all cases in period 1989-1991 and their immunohistochemical study. We compared results and determined distribution and relative frequency of each subtype. The prognostic indices and parameters are also included in our study.

References

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood 1997; 89:3909-3918.

Cecyn KZ, Oliveira JS, Alves AC, Silva MR, Kerbauy J. Prognostic factors in non-Hodgkin lymphomas. Sao Paulo Med J 2000; 118(1):7-12.

Elgin J, Phillips JG, Reddy W, Gibbs PO, Listinsky CM. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap. Ann Diagn Pathol 1999;3(5):263-75.

Frizzera G, Wu DC, Inghirami G. The Usefulness of Immunophenotypic and Genotypic Studies in the Diagnosis and Classification of Hematopoietic and Lymphoid Neoplasms. Am J Clin Pathol 1999; 11 l(Suppl 1):S13-S39.

Habermann TM. Non-Hodgkin's lymphoma: present status and future prospects. Hosp Pract (Off Ed) 1999;34(13):81-4, 87-8.

Harris NL, Jaffe ES, Dicbold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfleld CD. The World Health Organization classification of Neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10(12): 1419-32.

Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piriš MA, Ralfkaer E, Warnke RA. A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.

Harris NL. Hodgkin's disease: classification and differential diagnosis. Mod Pathol 1999; 12(2): 159-75.

Institute for Public Health of Federation Bosnia and Herzegovina. Vital Statistics for 2001.

Jaffe ES. Introduction: Hodgkin ’s Lymphoma - Pathology, Pathogenesis, and Treatment. Scm Hematol 1999;36:217-219.

Kitamura Y, Nanba E, Inui S, Tanigavva T, Ichihara K. Diagnosis of lymphoma in paraffin wax sections by nested PCR and immunohistochemistry. J Clin Pathol 1996;49(4):333-7.

Mason D, Gater K. Lymphoma classification. The pocket guide. Distributors Marston Book Services. Registered at the United Kingdom 1998.

Downloads

Published

18.05.2003

Issue

Section

Works

How to Cite

Malignant Lymphomas in Sarajevo Region According to WHO Classification of Lymphoid Neoplasms. (2003). Acta Medica Academica, 32, 137-150. https://doi.org/10.5644/Radovi.358

Most read articles by the same author(s)

1 2 > >>